Lenalidomid Viatris 5 mg, Hartkapseln - 21 Swissmedic Key 68557002 Registration Holder Viatris Pharma GmbH Name Lenalidomid Viatris 5 mg, Hartkapseln Date of registration 04.04.2022 Original/Generic Generic Introduction of Sequence 04.04.2022 ATC-Classification Lenalidomide (L04AX04) Revision date WHO WHO-DDD Valid until 03.04.2027 Index Therapeuticus (BSV) 07.16.10. Show package size 21 Index Therapeuticus (Swissmedic) 07.16.40. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 707.76 Limitation Yes Limitation text
Deductible 10 % Consumer price 786.15 Feedback FB Daily cost GTIN 7680685570024 Medication Code Synthetika Pharmacode Disponibility
Composition lenalidomidum 5.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, Kapselhülle: titanii dioxidum, gelatina, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.807 mg. Packungsbestandteile Galenic Form Capsules Excipiens Active Agent Dose Lenalidomidum 5 mg
BAG: Active Agent Dose Lenalidomidum 5 mg
Inactive agents additional_information (Nigrum) Amylum Pregelificatum Carmellosum Natricum Conexum Cellulosum Microcristallinum E 172 color. Gelatina Kalii Hydroxidum Lacca Drucktinte Natrii Stearylis Fumaras Propylenglycol Silica Colloidalis Anhydrica Titanium Dioxide Kapselhülle
Source Data was imported : 07.10.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
